2025年3月12日 · Developer of an alternative analysis system created to provide somatic mutation detection. The company's detection system consists of a non-invasive molecular test for …

2025年2月27日 · Developer of circulating DNA-based blood test for cancer diagnosis. The company's patented technology, IntPlex is based on cell-free circulating DNA analysis. This …

DiaDx has developed a revolutionary and non-invasive method for detection and monitoring of oncogenic mutations with a simple blood test. Circulating cell-free DNA analysis constitutes a …

2017年8月15日 · Experimental Design: We evaluated under blinded conditions the ability of cell-free DNA (cfDNA) to detect RAS / BRAF mutations in the plasma of 42 metastatic colorectal …

DIADX, société par actions simplifiée, immatriculée sous le SIREN 810672766, est active depuis 9 ans. Domiciliée à LES MATELLES (34270), elle est spécialisée dans le secteur d'activité de …

Find and fix vulnerabilities Codespaces. Instant dev environments

DIADX à LES MATELLES (34270) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS, SIREN, SIRET.

DiaDx — Consulting Organization from France, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement, Research sectors

La DIADx está diseñada para fortalecer los procesos de transformación digital de las empresas y formar una generación de ejecutivos con una visión integradora de lo que implica este cambio …

He is the principal founder of DiaDx SAS (Montpellier), which is devoted to providing liquid biopsy solutions in oncology.